Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey. - Wikidata - awgldk - TriplyDB

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

http://www.wikidata.org/entity/Q35145663

about

Current approaches in treatment of triple-negative breast cancer Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis.A study of the potential anticancer activity of Mangifera zeylanica bark: Evaluation of cytotoxic and apoptotic effects of the hexane extract and bioassay-guided fractionation to identify phytochemical constituents A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells

P2860

Q26801549-4AC7834B-3227-45FB-A0CA-09B7D6842E90 Q34049485-E2099C48-E171-42C8-B87C-FA6E6F88020F Q34411112-F470BC9A-D5BD-4B2F-8085-59FD68402261 Q36416237-37CD13CD-37A9-4E1E-B037-DA5497BFE753 Q36524847-ABD0FD1C-58AD-4BCE-8388-35DD8CD6F0DE Q37299652-BA3495BE-05F8-4303-932A-99534AFF96C6 Q37407219-EC125AC8-9218-4522-AB52-111EDE169BDC

P2860

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

http://www.wikidata.org/entity/Q35145663

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@ast

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@en

type

label

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@ast

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@en

prefLabel

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@ast

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@en

P1433

Q35145663-5618A49F-2A8A-46D3-ABD8-FFDDA745B6F9

P1476

Q35145663-1C4110C9-0973-4E27-BB10-F831EC51AEF8

P2093

Q35145663-61281CB9-763C-47F7-BAA0-46B6FBF1D05E

Q35145663-75C5FA32-B4C0-4FD8-A31C-FA6ED648C7A2

Q35145663-C42999A5-D697-4619-BABF-135DA436E822

P2860

Q35145663-0158274F-461E-4820-8EAF-DD19BDF140BC

Q35145663-03AAE6A8-2234-4286-BC63-F4995A973FE7

Q35145663-04EBD84B-CAFD-42EF-A24E-0A76654EE048

Q35145663-068E4892-F89E-4AF0-B425-F9C064A9C59D

Q35145663-0C81DA3B-28A1-4F35-B777-3CA73F9CA1DE

Q35145663-0FED1ACE-3D00-4ADB-A6B1-EE4A7C9AEEFE

Q35145663-1937323F-C83B-40D6-A618-72C5380F504A

Q35145663-1BABC487-86A6-4B48-9B27-17747C3A72FD

Q35145663-2082D78C-3F7C-42D5-8C40-5EEE6BF2D793

Q35145663-2F00F919-33F6-4EED-855D-25A65396CDB7

P304

Q35145663-62F9FD69-C71C-45C0-9F0D-F68BAFC2F0D4

P31

Q35145663-D27F5751-F2BC-4E64-BB29-55BFC97419B0

P356

Q35145663-A4F3A71D-06BF-4A9B-BF7D-30D97130E8B7

P433

Q35145663-7574B3B4-7100-40A6-9A8A-6D7AFD8736C3

P478

Q35145663-489C2B1C-1D09-40D3-9375-7DC57142747F

P577

Q35145663-87FF9CDE-CB12-46CE-939E-442333E03F9C

P5875

Q35145663-8B897992-1408-421D-9D99-B050063EBBE4

P698

Q35145663-69A9444B-52AF-496C-9CC8-B64A321727C3

P921

Q35145663-5C6AAD8B-B632-4967-A235-4C7DF0C0CB5A

P932

Q35145663-7A040571-23F7-47E6-89CF-619F5165E1C1

P356

P1433

Current Oncology

P1476

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

@en

P2093

L Provencher

http://www.w3.org/2001/XMLSchema#string

R Dent

http://www.w3.org/2001/XMLSchema#string

S Verma

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

Triple-Negative Breast Cancer

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Hallmarks of 'BRCAness' in sporadic cancers

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.

Triple-negative breast cancer: clinical features and patterns of recurrence.

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers

P304

180-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.V18I4.913

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51602137

http://www.w3.org/2001/XMLSchema#string

P698

21874117

http://www.w3.org/2001/XMLSchema#string

P921

P932

3149546

http://www.w3.org/2001/XMLSchema#string